Cempra Inc (CEMP)

24.20
0.32 1.34
NASDAQ : Health Care
Prev Close 23.88
Open 24.68
Day Low/High 23.77 / 25.00
52 Wk Low/High 14.03 / 46.99
Volume 1.65M
Avg Volume 810.10K
Exchange NASDAQ
Shares Outstanding 51.99M
Market Cap 1.24B
EPS -2.10
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

These 5 Biotech Stocks Are Ready for a Volatility Break

These 5 Biotech Stocks Are Ready for a Volatility Break

The squeeze is on these stocks, and they are poised for volatile moves.

Cempra To Present Solithromycin At FDA Antimicrobial Drugs Advisory Committee Meeting On November 4, 2016

Cempra To Present Solithromycin At FDA Antimicrobial Drugs Advisory Committee Meeting On November 4, 2016

FDA currently reviewing NDAs for IV and oral solithromycin for community-acquired bacterial pneumonia, with PDUFA dates in late December

Cempra Announces European Medicines Agency Validates MAA For Solithromycin For Treatment Of CABP

Cempra Announces European Medicines Agency Validates MAA For Solithromycin For Treatment Of CABP

Formal review of solithromycin by EMA now underway

Perilous Reversal Watch: Cempra (CEMP)

Perilous Reversal Watch: Cempra (CEMP)

Trade-Ideas LLC identified Cempra (CEMP) as a "perilous reversal" (up big yesterday but down big today) candidate

Cempra (CEMP) Is Today's Strong On High Volume Stock

Cempra (CEMP) Is Today's Strong On High Volume Stock

Trade-Ideas LLC identified Cempra (CEMP) as a strong on high relative volume candidate

Cempra To Report Second Quarter 2016 Financial Results

Cempra To Report Second Quarter 2016 Financial Results

Management to host webcast and conference call on August 1, 2016 at 4:30 p.m. EDT

Antibiotic for Treatment of Superbugs Could Send Cempra Shares Soaring

Antibiotic for Treatment of Superbugs Could Send Cempra Shares Soaring

Solithera is well along in the FDA approval process, and if the antibiotic is approved, the North Carolina-based company will have a potential blockbuster drug.

Cempra (CEMP) Is Today's Strong On High Volume Stock

Cempra (CEMP) Is Today's Strong On High Volume Stock

Trade-Ideas LLC identified Cempra (CEMP) as a strong on high relative volume candidate

Cempra Submits Marketing Authorization Application To EMA For Solithromycin In The Treatment Of Community-Acquired Bacterial Pneumonia

Cempra Submits Marketing Authorization Application To EMA For Solithromycin In The Treatment Of Community-Acquired Bacterial Pneumonia

Marketing Authorization Application (MAA) submitted for Europe for intravenous and for oral capsules

Commit To Purchase Cempra At $15, Earn 36.5% Annualized Using Options

Commit To Purchase Cempra At $15, Earn 36.5% Annualized Using Options

Investors considering a purchase of Cempra Inc shares, but cautious about paying the going market price of $18.19/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the January 2017 put at the $15 strike, which has a bid at the time of this writing of $3.20.

Strong On High Volume: Cempra (CEMP)

Strong On High Volume: Cempra (CEMP)

Trade-Ideas LLC identified Cempra (CEMP) as a strong on high relative volume candidate

Today's Dead Cat Bounce Stock: Cempra (CEMP)

Today's Dead Cat Bounce Stock: Cempra (CEMP)

Trade-Ideas LLC identified Cempra (CEMP) as a "dead cat bounce" (down big yesterday but up big today) candidate

Cempra (CEMP) Stock: Weak On High Volume Today

Cempra (CEMP) Stock: Weak On High Volume Today

Trade-Ideas LLC identified Cempra (CEMP) as a weak on high relative volume candidate

Cempra (CEMP): Today's Weak On High Volume Stock

Cempra (CEMP): Today's Weak On High Volume Stock

Trade-Ideas LLC identified Cempra (CEMP) as a weak on high relative volume candidate

Cempra (CEMP) Strong On High Relative Volume Today

Cempra (CEMP) Strong On High Relative Volume Today

Trade-Ideas LLC identified Cempra (CEMP) as a strong on high relative volume candidate